| Literature DB >> 28130842 |
Rimei Nishimura1,2, Hironari Sano1,3, Yoshiko Onda1, Daisuke Tsujino1, Kiyotaka Ando1, Futoshi Ebara1, Toru Matsudaira1, Shinichiro Ishikawa3, Takuya Sakamoto3, Naoko Tajima4, Kazunori Utsunomiya1.
Abstract
AIMS/Entities:
Keywords: Children; Insulin deficiency; Insulin resistance
Mesh:
Substances:
Year: 2017 PMID: 28130842 PMCID: PMC5583948 DOI: 10.1111/jdi.12637
Source DB: PubMed Journal: J Diabetes Investig ISSN: 2040-1116 Impact factor: 4.232
Participant characteristics
| Boys | Girls |
| |
|---|---|---|---|
|
| 252 | 193 | |
| BMI (kg/m2) | 19.2 (18.0–20.7) | 20.4 (18.9–22.0) | <0.001 |
| Fasting PG (mg/dL) | 93 (88–98) | 90 (86–94) | <0.001 |
| Fasting IRI (μIU/mL) | 5.4 (3.5–7.5) | 6.4 (4.7–8.9) | <0.001 |
| 5th, 10th, 90th, 95th percentile | 1.7, 2.2, 10.0, 12.9 | 2.0, 3.1, 12.5, 17.2 | |
| HOMA‐IR | 1.2 (0.8–1.7) | 1.5 (1.0–2.0) | 0.002 |
| 5th, 10th, 90th, 95th percentile | 0.4, 0.5, 2.3, 3.0 | 0.5, 0.7, 2.8, 3.8 | |
| HOMA‐β | 64 (44–93) | 86 (63–120) | <0.001 |
| 5,10, 90, 95 percentile | 0.4, 0.5, 2.3, 3.0 | 0.5, 0.7, 2.8, 3.8 | |
| Disposition index | 52 (43–64) | 60 (50–74) | <0.001 |
| 5,10, 90, 95 percentile | 20, 29, 127, 163 | 25, 44, 177, 241 | |
| Obesity | 25 (9.9) | 21 (10.7) | 0.787 |
| HOMA‐IR ≥2.5 | 22 (8.7) | 30 (15.5) | 0.027 |
| HOMA‐β <40 | 52 (20.6) | 17 (8.8) | 0.001 |
| Obesity + IR | 6 (2.4) | 9 (4.7) | 0.186 |
| Obesity + ID | 1 (0.4) | 1 (0.5) | 1 |
| IR + ID | 0 (0.0) | 0 (0.0) | – |
Figures in parentheses are interquartile ranges (25–75th percentiles) or %. All P‐values were calculated using the Mann–Whitney test, and all proportions were tested for significance by using χ2‐test or Fisher's exact probability test. HOMA‐β, homeostasis model assessment of β‐cell function; HOMA‐IR, homeostasis model assessment of insulin resistance; ID, homeostasis model assessment of β‐cell function <40; IR, homeostasis model assessment of insulin resistance <2.5; IRI, immunoreactive insulin; PG, plasma glucose.
Figure 1Distribution of (a) homeostasis model assessment of insulin resistance (HOMA‐IR) values and the proportion of participants with HOMA‐IR ≥2.5; (b) homeostasis model assessment of β‐cell function (HOMA‐β) values and proportion of participants with HOMA‐β <40; and (c) Disposition Index values by sex.
Figure 2Correlation between (a) homeostasis model assessment of insulin resistance (HOMA‐IR) values and body mass index (BMI), between (b) homeostasis model assessment of β‐cell function (HOMA‐β) values and BMI, and between (c) Disposition Index values and BMI by sex. r, Spearman's rank correlation coefficient.